TomTec launches its 2D Cardiac Performance Analysis© software as part of TomTec’s CardioArena™ multimodality imaging solution at the American Society of Echocardiography congress 2009 in Washington and received approval from the U.S. Food and Drug Administration (FDA) for its 2D CPA, a Vendor Independent Solution for Strain and Time to Peak Velocity Analysis Based on Speckle Tracking.
2D Cardiac Performance Analysis allows cardiologists to study the behaviour of the heart muscle quickly and easily. Quantitative assessment of displacement, velocity and strain in individual muscle segments is available. The diagnosis of pathologies like hypertrophic cardiomyopathy or dyssynchronous ventricles improves with this software and the decision for a cardiac resynchronisation therapy is then more confident.
2D Cardiac Performance Analysis© is a speckle tracking based analysis tool which can analyze 2D data from various ultrasound machines. The user can utilize the data of different ultrasound systems and is not limited to specific vendors. Already acquired studies can also be analysed with TomTec’s 2D Cardiac Performance Analysis.
Frank Schlau, TomTec’s Chief Marketing Officer said, 2D Cardiac Performance Analysis© runs within TomTec’s CardioArena™ environment which provides connectivity to multivendor Echo labs. This solution is user oriented and fulfils the demands of cardiologists towards a simplified workflow.